International General Insurance Holdings Ltd.
IGIC Nasdaq Insurance Carriers, Nec Financials FY2021–FY2025
Last close · Oct 23, 2026
$24.74
1.3%What International General Insurance Holdings Ltd. does
No business description yet.
- Legal name
- International General Insurance Holdings Ltd.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Apr 21, 2026
- Accession · CIK
- 0001794338-26-000012
0001794338
Revenue and margins
International General Insurance Holdings Ltd. had $517M of revenue in fiscal 2025, down 4.1% on the year before.
Net income and earnings per share
From fiscal 2021 to 2025, diluted EPS grew 31.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $107M in fiscal 2025, 20.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
International General Insurance Holdings Ltd. returned $108M to shareholders in fiscal 2025, 101% of free cash flow. The diluted share count fell 2.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably International General Insurance Holdings Ltd. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $242M | $388M | $219M | $155M | $186M |
| Total assets | — | $1.6B | $1.8B | $2.0B | $2.1B |
| Total liabilities | — | $1.2B | $1.3B | $1.4B | $1.4B |
| Shareholders' equity | $381M | $411M | $540M | $655M | $710M |
| Net debt (− = net cash) | — | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✓ | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✕ |
| Debt fell relative to assets | — | — | — | — | — |
| Current ratio rose | — | — | — | — | — |
| Share count didn't rise | — | ✕ | ✓ | ✕ | ✓ |
| Gross margin rose | — | — | — | — | — |
| Revenue rose relative to assets | — | — | ✓ | ✕ | ✕ |
| F-score | — / 3 | — / 4 | — / 6 | — / 6 | — / 6 |
| Accruals ratio | — | −4.2% | −4.6% | −3.8% | 0.9% |
| Altman Z'' | — | — | — | — | — |
5 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $350M | $393M | $499M | $539M | $517M |
| Operating income | −$302M | −$306M | −$346M | — | — |
| Pretax income | $48.6M | $92.2M | $126M | $132M | $127M |
| Income tax | $1.8M | $2.9M | $7.9M | −$2.9M | −$0.0M |
| Net income | $46.8M | $89.2M | $118M | $135M | $127M |
| Net income to common | — | $84.2M | $111M | $133M | $126M |
| Diluted EPS | $0.98 | $1.84 | $2.55 | $2.98 | $2.89 |
| Diluted shares | 0.05B | 0.05B | 0.04B | 0.04B | 0.04B |
| Cash flow | |||||
| Cash from operations | $175M | $155M | $197M | $209M | $108M |
| Capital expenditure | $2.4M | $1.3M | $3.2M | $6.6M | $0.9M |
| Free cash flow | $173M | $154M | $193M | $203M | $107M |
| Depreciation and amortization | $2.8M | $3.1M | $2.5M | $3.4M | $3.6M |
| Stock-based compensation | $1.2M | $2.3M | $3.2M | $4.6M | $6.8M |
| Acquisitions | $0.1M | $0.0M | $1.1M | $0.0M | $0.0M |
| Share buybacks | — | $2.4M | $31.1M | $23.2M | $61.9M |
| Dividends paid | $15.1M | $10.2M | $1.7M | $26.5M | $46.2M |
| Dividends and buybacks | $15.1M | $12.5M | $32.8M | $49.7M | $108M |
| Balance sheet | |||||
| Cash and short-term investments | $242M | $388M | $219M | $155M | $186M |
| Total assets | — | $1.6B | $1.8B | $2.0B | $2.1B |
| Total liabilities | — | $1.2B | $1.3B | $1.4B | $1.4B |
| Shareholders' equity | $381M | $411M | $540M | $655M | $710M |
| Margins | |||||
| Operating margin | −86.1% | −77.7% | −69.3% | — | — |
| EBITDA margin | −85.3% | −76.9% | −68.8% | — | — |
| Net margin | 13.4% | 22.7% | 23.7% | 25.1% | 24.6% |
| FCF margin | 49.4% | 39.1% | 38.7% | 37.6% | 20.7% |
| Returns | |||||
| Return on equity | 12.3% | 22.5% | 24.8% | 22.6% | 18.6% |
| Return on assets | — | 5.6% | 6.9% | 7.0% | 6.1% |
| Return on tangible equity | 12.3% | 20.5% | 20.5% | 20.3% | 17.8% |
| Growth | |||||
| Revenue growth | — | 12.2% | 27.0% | 8.0% | −4.1% |
| Net income growth | — | 90.6% | 32.5% | 14.3% | −5.9% |
| EPS growth | — | 87.8% | 38.6% | 16.9% | −3.0% |
| FCF growth | — | −11.2% | 25.9% | 4.9% | −47.2% |
| Share count change | — | 0.3% | −4.8% | 2.9% | −2.4% |
| Capital allocation | |||||
| Capex / revenue | 0.7% | 0.3% | 0.7% | 1.2% | 0.2% |
| Stock comp / revenue | 0.3% | 0.6% | 0.7% | 0.9% | 1.3% |
| Payouts / FCF | 8.7% | 8.2% | 17.0% | 24.5% | 100.9% |
| Quality scores | |||||
| Accruals ratio | — | −4.2% | −4.6% | −3.8% | 0.9% |
Source: SEC EDGAR XBRL filings (CIK 0001794338). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.